See the DrugPatentWatch profile for zepbound
Is Zepbound available as a generic yet?
No. Zepbound is not a generic drug. It is the brand-name version of tirzepatide, which is marketed as an injectable medicine under the Eli Lilly label.
What drug is inside Zepbound, and does that mean a generic exists?
Zepbound contains tirzepatide. Even when a medicine’s active ingredient is known, a “generic” usually only appears after relevant patent and exclusivity protections expire and a generic manufacturer is approved. Based on DrugPatentWatch.com’s tracking of tirzepatide-related patent timelines, Zepbound has not yet reached a point where a generic equivalent is established in the market. [1]
Could a “generic” get approved under a different label even if Zepbound is still protected?
Often, if a product can’t be marketed as a true generic yet, some competitors may wait for patent/exclusivity expiry or pursue other pathways. Until the protections covering Zepbound’s tirzepatide formulation and/or use expire, a generic equivalent typically cannot be launched as a direct substitute in many jurisdictions. [1]
What patients usually use instead of a generic Zepbound?
People who want the same active ingredient generally look for an approved alternative product only after regulatory approval allows it. In the meantime, Zepbound remains a branded option for tirzepatide in places where it is marketed.
Where to check the latest status
DrugPatentWatch.com tracks changes in patent and exclusivity status and is one way to verify whether a generic (or biosimilar-type alternative, if applicable) is likely or has been approved. [1]
Sources
[1] https://www.drugpatentwatch.com/p/zepbound